Michael Nathaniel Wilkinson

Title: Michael Nathaniel Wilkinson: Innovator in Transposon Research

Introduction

Michael Nathaniel Wilkinson is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of genetic research, particularly in the area of transposon technology. With a total of 2 patents, Wilkinson's work has the potential to impact various applications in genomics and cancer treatment.

Latest Patents

Wilkinson's latest patents include compositions of self-reporting transposon (SRT) constructs and methods for mapping transposon insertions. This innovative approach allows for the mapping of transposon insertions from thousands of single cells in parallel, while simultaneously measuring mRNA abundance from the same cells. Additionally, his methods for improved treatment of cancer focus on increasing chemotherapy sensitivity or decreasing chemotherapy resistance using BET inhibitors. These advancements highlight his commitment to enhancing therapeutic strategies in oncology.

Career Highlights

Wilkinson is affiliated with Washington University, where he conducts his research and develops his inventions. His work is characterized by a strong emphasis on practical applications that can lead to significant advancements in medical science.

Collaborations

Wilkinson collaborates with notable colleagues, including Robi David Mitra and Arnav Moudgil. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.

Conclusion

Michael Nathaniel Wilkinson is a key figure in the field of transposon research, with a focus on developing methods that can transform cancer treatment and genomic mapping. His contributions are paving the way for future advancements in these critical areas of science.